Funding opportunities

Below is a list of funding opportunities that may be relevant for thoracic cancer research, including basic scientific research. Please read the funding guidelines to determine if your research proposal is eligible and that you meet other eligibility requirements.

Any TOGA member can apply for TOGA endorsement of their thoracic cancer research proposal, taking advantage of peer- and consumer-review by TOGA working groups in the following areas:

  1. Early non small cell lung cancer
  2. Advanced non small cell lung cancer
  3. Small cell lung cancer/mesothelioma
  4. Supportive and palliative care
  5. Translational research

TOGA endorsement offers the following benefits:

  • Use of TOGA logo or TOGA acknowledgment on all applications, presentations and publications
  • Membership mailouts to assist with recruitment
  • Listing of trial on the TOGA website
  • Updates presented at Scientific Committee or other TOGA meetings (time permitting)

Further information is available in the TOGA Endorsement Policy.

The next deadline for submission of concepts for peer- and consumer review and application for endorsement is 2 May. Send concepts to

If you know of additional funding opportunities that we can list, please contact

Grant NameResearch fundedGrant open dateClose dateMax fundingDurationApplication requirements
NHMRC Clinical Trials and Cohort Studies GrantsClinical trials and cohort studies29 June 2022Min data 27 July 2022
Full application24 August 2022
Based on assessment of the requested budget. 1-5 yearsSapphire
Priority-driven Collaborative Cancer Research Scheme (PdCCRS)Standard grants
Early Career Researcher grants
(Lung cancer is a priority area)
9 March 202231 August 2022 (17:00 AEST)$200,000/year1-3 yearsNHMRC Clinical trials and cohort application
PdCCRS Questions application forms
MRFF Clinical Trials Activity Initiative - 2022 International Clinical Trial Collaborations Grant OpportunitySupports Australian medical research and medical innovation projects that promote Australian involvement in international collaborative investigator-initiated clinical trials
research through the establishment and co-ordination of clinical trial site/s in Australia, for an internationally-led trial. An Australian-led trial inviting international site participation can also fund coordination of those international trial sites through this grant funding.
The clinical trial should not have commenced recruitment at the Australian trial
30 March 2022Min data 8 Feb 2023 (17:00 ACT time)
Full application due 22 February 2023 (17:00 ACT time)
$3 million5 yearsApplication form
Where applicants are proposing to lead an international collaborative clinical trial, MRFF funding is available to support overarching coordination of trial sites both in Australia and overseas and to operate one or more clinical trial sites in Australia. Grant cannot support conduct at international clinical trial sites. (The international counterpart will need to find this funding)
Alternatively, where applicants are proposing to contribute to
clinical trials initiated by the international partners, MRFF funding is available to coordinate Australian
involvement and to conduct one or more clinical trial sites in Australia.